Sphera Funds Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-36,050
| Closed | -$68.5K | – | 111 |
|
|
2024
Q2 | $68.5K | Sell |
36,050
-231,200
| -87% | -$439K | 0.01% | 110 |
|
|
2024
Q1 | $759K | Buy |
267,250
+83,600
| +46% | +$237K | 0.11% | 88 |
|
|
2023
Q4 | $2.7M | Sell |
183,650
-10,000
| -5% | -$147K | 0.44% | 59 |
|
|
2023
Q3 | $3.55M | Buy |
193,650
+93,650
| +94% | +$1.71M | 0.65% | 50 |
|
|
2023
Q2 | $2.16M | Buy |
+100,000
| New | +$2.16M | 0.34% | 59 |
|